Keating K M
ImmuLogic Pharmaceutical Corporation,Waltham, MA, USA.
J Biomol Tech. 1999 Jun;10(2):72-81.
Racemization of amino acids during solid-phase synthesis of peptides leads to the formation of side products that are chirally modified peptides. The chiral specificity of enzymes can be exploited to identify the sites of the modifications in these impurities. One such impurity, designated X5, was isolated from the target peptide, Fel-1, and demonstrated to be an optical isomer of Fel-1 by N-terminal sequencing and mass spectrometry. A chymotryptic digest was done on the isolated X5 and Fel-1. The fragments were separated on reversed-phase high-performance liquid chromatography (HPLC). Mass spectral data on the fragment from X5, with a different retention time from the analogous fragment of Fel-1, suggested that the modification was in the N-terminal portion of the peptide. Enzymatic digestion by Asp-N protease followed by HPLC of the fragments and mass spectral analysis provided evidence that an aspartic acid at position 5 was a D-amino acid in X5, because that position was not cleaved. These results contributed to the identification of X5 as an optical isomer of Fel-1, with a D-aspartic acid replacing an L-aspartic acid normally present at position 5.
在肽的固相合成过程中,氨基酸的消旋化会导致形成手性修饰肽的副产物。可以利用酶的手性特异性来确定这些杂质中修饰的位点。从目标肽Fel-1中分离出一种这样的杂质,命名为X5,并通过N端测序和质谱证明它是Fel-1的光学异构体。对分离出的X5和Fel-1进行了胰凝乳蛋白酶消化。片段在反相高效液相色谱(HPLC)上进行分离。X5片段的质谱数据与Fel-1的类似片段保留时间不同,表明修饰位于肽的N端部分。用天冬氨酸蛋白酶(Asp-N protease)进行酶切,然后对片段进行HPLC和质谱分析,结果表明X5中第5位的天冬氨酸是D-氨基酸,因为该位置未被切割。这些结果有助于确定X5是Fel-1的光学异构体,其中D-天冬氨酸取代了正常位于第5位的L-天冬氨酸。